Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Dalian Bio-Chem Co's Revenue for the
three
months ended in Jun. 2026 was ¥316 Mil. Dalian Bio-Chem Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was ¥241 Mil.
Hence, Dalian Bio-Chem Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 1.31.
Dalian Bio-Chem Co (SHSE:603360) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Dalian Bio-Chem Co Receivables Turnover Related Terms
Dalian Bio-Chem Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Dalian Bio-Chem Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603360 vs LIN, SHW, ECL: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Dalian Bio-Chem Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dalian Bio-Chem Co Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Dalian Bio-Chem Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Dalian Bio-Chem Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dalian Bio-Chem Co (SHSE:603360) has a Receivables Turnover of 1.31 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Dalian Bio-Chem Co and its competitors. According to the industry distribution chart, Dalian Bio-Chem Co ranks #706 out of 1583 companies in the Chemicals industry, placing it in the top 44.6%.
Is Dalian Bio-Chem Co's Receivables Turnover too high?
Dalian Bio-Chem Co's current Receivables Turnover is 1.31. The Chemicals industry median Receivables Turnover is 5.74. Dalian Bio-Chem Co's value of 1.31 is 77.2% below this industry median. Based on the distribution chart, Dalian Bio-Chem Co ranks #706 out of 1583 companies in the Chemicals industry, which is above the industry midpoint. Overall, Dalian Bio-Chem Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dalian Bio-Chem Co's Receivables Turnover compare to LIN and SHW?
According to the Chemicals industry distribution chart, Dalian Bio-Chem Co ranks #706 out of 1583 companies for Receivables Turnover. This puts Dalian Bio-Chem Co in the upper half of its industry. The industry median Receivables Turnover is 5.74. Dalian Bio-Chem Co's value of 1.31 is 77.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.74, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dalian Bio-Chem Co's current Receivables Turnover of 1.31 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Dalian Bio-Chem Co and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dalian Bio-Chem Co's current Receivables Turnover is 1.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dalian Bio-Chem Co stock overvalued right now?
Based on GuruFocus' analysis, Dalian Bio-Chem Co (SHSE:603360) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥20.57, compared to a current price of ¥13.51 — trading 34.3% below its estimated fair value. The current Receivables Turnover is 1.31 and 77.2% below the Chemicals industry median of 5.74. Dalian Bio-Chem Co's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Dalian Bio-Chem Co (SHSE:603360), the current Receivables Turnover is 1.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dalian Bio-Chem Co (SHSE:603360) Overvalued in 2026?
Based on GuruFocus' analysis, Dalian Bio-Chem Co stock appears to be undervalued.
The current stock price of ¥13.51 is trading 34.3% below its estimated GF Value™ of ¥20.57.
GuruFocus considers Dalian Bio-Chem Co to be Significantly Undervalued.
Key valuation signals for SHSE:603360:
Receivables Turnover: 1.31
GF Value™: ¥20.57 vs. price of ¥13.51 (34.3% below fair value)
Industry Position: 77.2% below the Chemicals median (#706 of 1583)
No single metric tells the full story. See the SHSE:603360 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dalian Bio-Chem Co Ltd is a chemical manufacturing company. It is engaged in manufacturing of bactericides, antiseptics and fungicides for different industrial applications including water treatment, coatings, construction materials and among others. The company's products are used in the fields of paper and pulping, water treatment, metal working fluid, plastics, paints and coatings, marine paints, wood preservations, leather treatment, cosmetics, personal care, oil-field, textiles and dye, fiber, carpets, and construction and building materials.
73GF Score
Get the complete analysis for SHSE:603360
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603360 has been successfully added to your 
